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Abstract
Entry of Staphylococcus aureus into the bloodstream can lead to metastatic abscess formation and infective endocarditis.
Crucial to the development of both these conditions is the interaction of S. aureus with endothelial cells. In vivo and in vitro
studies have shown that the staphylococcal invasin FnBPA triggers bacterial invasion of endothelial cells via a process that
involves fibronectin (Fn) bridging to a5b1 integrins. The Fn-binding region of FnBPA usually contains 11 non-identical
repeats (FnBRs) with differing affinities for Fn, which facilitate the binding of multiple Fn molecules and may promote
integrin clustering. We thus hypothesized that multiple repeats are necessary to trigger the invasion of endothelial cells by
S. aureus. To test this we constructed variants of fnbA containing various combinations of FnBRs. In vitro assays revealed that
endothelial cell invasion can be facilitated by a single high-affinity, but not low-affinity FnBR. Studies using a nisin-inducible
system that controlled surface expression of FnBPA revealed that variants encoding fewer FnBRs required higher levels of
surface expression to mediate invasion. High expression levels of FnBPA bearing a single low affinity FnBR bound Fn but did
not invade, suggesting that FnBPA affinity for Fn is crucial for triggering internalization. In addition, multiple FnBRs
increased the speed of internalization, as did higher expression levels of FnBPA, without altering the uptake mechanism.
The relevance of these findings to pathogenesis was demonstrated using a murine sepsis model, which showed that
multiple FnBRs were required for virulence. In conclusion, multiple FnBRs within FnBPA facilitate efficient Fn adhesion,
trigger rapid bacterial uptake and are required for pathogenesis.
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Introduction
Staphylococcus aureus is a major human pathogen and the
continuous emergence and spread of antibiotic resistant strains
(e.g. MRSA, VRSA) mean treatment options are often severely
limited [1,2]. Despite its normal role as a commensal organism
living asymptomatically in the nasal cavities of a large proportion
of the human population [3], S. aureus is also responsible for a raft
of different infections that range in both anatomical site and
severity. These infections are facilitated by a vast array of different
virulence factors such as adhesins, invasins, toxins and modulins,
which not only enable evasion of host immune responses [4,5], but
also contribute to colonization, dissemination, tissue damage and
transmission [1].
Whilst some infections are superficial and self-limiting, S. aureus
is also responsible for serious invasive diseases. Indeed, S. aureus is a
leading cause of sepsis and infective endocarditis [1,6–8].
Colonization of the heart and subsequent formation of vegetations
involves a number of complex interactions [9–11]. Animal studies
have shown that staphylococcal fibronectin-binding protein A
(FnBPA) is able to support the colonization of heart valves by
otherwise non-pathogenic Lactococcus lactis, as well as promote
dissemination into the spleen [12,13]. In addition, FnBPs were
significantly associated with systemic inflammation, severe weight
loss and mortality in a murine sepsis model [14]. The role of
FnBPA in virulence is supported by in vitro work showing that L.
lactis expressing FnBPA is able to activate endothelial cells,
inducing inflammatory and pro-coagulant responses [15,16]. In
addition to binding fibronectin (Fn) and fibrinogen, FnBPA
promotes attachment to the endothelium and triggers the uptake
of S. aureus by endothelial cells, which is believed to facilitate
bacterial persistence and the establishment of secondary (meta-
static) infections [17–21].
In common with several other bacterial pathogens, S. aureus
invades endothelial cells via cell surface integrins [22–24]. The
bacterium binds Fn, which is attached to the endothelial cell by
a5b1 integrins [18,19]. This triggers bacterial uptake via a host-cell
driven process involving actin remodelling, focal adhesion kinase
and Src family kinases [25,26]. In vitro studies suggest that Fn on
the surface of endothelial cells is sufficient for S. aureus-integrin
bridging and thus binding of exogenous Fn (e.g. from plasma) is
not required [19,26].
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In addition to FnBPA, many strains express a second, related,
Fn-binding protein (FnBPB). Indeed, the majority of clinical
isolates screened encode both (77%), whilst the remainder encode
just FnBPA (22%) or, rarely, just FnBPB (1%) [27]. Both proteins
have N-terminal domains that bind fibrinogen and elastin [28,29]
followed by a region containing 11 (FnBPA) or 10 (FnBPB) non-
identical repeats that are responsible for binding F1 modules in the
N-terminal domain of Fn [30,31]. Studies using synthesized
peptides have demonstrated that some FnBRs (1, 4, 5, 9, 10 and
11) have a high affinity for Fn, whilst the others have a much lower
affinity [30,31]. The repeat region is intrinsically disordered,
allowing the relatively small FnBRs (27–39 aa) to bind the much
larger Fn molecule with high affinity [31]. It has been
hypothesized that this arrangement enables a single FnBPA
protein to bind multiple Fn molecules, leading to integrin
clustering and bacterial uptake [30,32,33]. Previous work, using
an old organizational scheme for FnBPA based solely on amino
acid sequence similarity demonstrated that partial deletions in the
repeat region did not detectably diminish the ability of bacteria to
bind Fn or invade endothelial cells [13,19]. However, because it is
difficult to relate this work to the new domain organization based
on structural data [30,31], it is not clear how many FnBRs are
necessary for, or how the affinity of a given repeat for Fn affects
invasion of host cells. Furthermore, it is unknown how the
bacterium benefits from such apparent redundancy. This study
addresses these questions by using bacteria expressing FnBPA
variants containing various combinations of FnBRs to dissect their
role in Fn-binding, the invasion of endothelial cells and virulence
in a murine sepsis model.
Results
Construction of FnBPA variants
FnBPA contains 11 non-identical repeats with either high or low
affinity for fibronectin (Fig. 1A). FnBPA variants were generated
using a technique based on the circular PCR approach described
by Massey et al. [13] (Fig. 1A, B and Table 1). Primers were
modified to include 59 phosphate, which facilitated simple blunt-
ended ligation of PCR products to form a plasmid encoding fnbA
variants lacking DNA encoding various repeats (Fig. 1B). Certain
constructs were themselves used as templates to produce further
fnbA variants (Table 1). Previous work (using the old domain
organizational scheme (Fig. 1A)), suggested that only a few repeats
were needed to confer binding to fibronectin and invasion of
endothelial cells [13,19] and we therefore produced FnBPA
variants containing various combinations of 1–3 repeats. As such,
3 different types of construct were produced; those containing a
mixture of high- and low-affinity repeats, those containing just
high-affinity repeats and those containing just low-affinity repeats
(Fig. 1C). Western immunoblots confirmed expression of each of
the constructs, which appeared as bands of the expected size
(Fig. 1D). DNA sequencing ensured the integrity of each construct
(data not shown).
Surface expression levels of FnBPA are equivalent
between variants
To verify that each of the FnBPA variants were expressed at
equivalent concentrations we employed an ELISA approach using
antibodies raised to the N-terminal region of FnBPA that is
conserved between our variants. Standard plots (Fig. S1) indicated
that this would allow us to accurately measure FnBPA expression
levels and detect any differences between variants. Because S.
aureus expresses protein A, we used a S. aureus DfnbA/B (Dfnb) strain
(DU5883) as the blank in our ELISA assay, meaning that values
relate purely to FnBPA expression levels. As expected from our
Western immunoblot data (Fig. 1D), FnBPA expression levels in
the 8325.4 wild-type (WT) strain were low (Fig. 2A). These levels
were higher amongst the bacteria expressing plasmid-encoded
FnBPA, which were equivalent between variants (Fig. 2A).
We also measured FnBPA expression by quantifying adhesion
of S. aureus expressing each FnBPA variant to immobilized
fibrinogen (Fig. 2B). Fibrinogen binding is conferred by the N-
terminal region that is constant in all of the variants [28].
Attachment to fibrinogen was maintained in the 8325.4 Dfnb strain
due to the presence of fibrinogen-binding ClfA and ClfB proteins.
However, binding of S. aureus expressing plasmid-encoded FnBPA
was significantly enhanced above that of the 8325.4 WT or Dfnb
strains, reflecting the higher levels of plasmid-encoded FnBPA,
which was equal between variants indicating equivalent expression
levels (Fig. 2B).
A single high-affinity FnBR is sufficient for FnBPA-
mediated adhesion to Fn and invasion of endothelial
cells
Previous work using synthesized peptides [31] determined that
some FnBRs have a high affinity for Fn, whilst others bind more
weakly (Fig. 1A). To examine how the composition of the Fn-
binding region of FnBPA affects both adhesion to Fn and
endothelial cell invasion, various combinations of FnBPA repeats
were expressed on the surface of a S. aureus 8325.4 mutant strain
lacking both FnBPA and FnBPB [34]. In keeping with previous
work [19,34], S. aureus lacking FnBPs exhibited significantly
reduced binding to Fn (Fig. 3A) and invasion of endothelial cells
(Fig. 3B; Fig. S2). S. aureus expressing FnBPA lacking the entire Fn-
binding repeat region (FnBPR0) did not adhere to Fn or invade
endothelial cells above the levels of the FnBP-deficient mutant
(Fig. 3A, B). Expression of FnBPA from the plasmid was higher
than that of WT bacteria (Fig. 2A, B) and accordingly S. aureus
FnBPR1-11 bound Fn more strongly than WT 8325.4 (Fig. 3A).
Bacteria expressing FnBPA variants with increasing numbers of
high-affinity repeats bound Fn incrementally, where three repeats
Author Summary
Staphylococcus aureus is a frequent cause of bacteremia
and sepsis. Adhesion to and invasion of endothelial cells
lining blood vessels by S. aureus can lead to colonization of
the heart valves and/or dissemination into surrounding
tissues and the establishment of secondary (metastatic)
infections. Uptake by endothelial cells is triggered by the
interaction of fibronectin-binding protein A (FnBPA) with
host cell receptors called integrins via a fibronectin (Fn)
bridge. FnBPA contains 11 non-identical repeats (FnBRs)
that mediate binding to Fn. Previous work has shown that
partial deletions in the FnBR region do not significantly
affect binding to Fn or invasion of host cells in vitro. It was
therefore unclear why FnBPA contains so many repeats.
This work demonstrates that the number of repeats affects
the amount of surface-exposed FnBPA required to trigger
invasion, as well as affecting the speed of uptake. As such,
the presence of multiple repeats within FnBPA facilitates
adhesion and invasion even at low surface expression
levels. Experiments using a murine model of sepsis
demonstrate that these differences have a significant
impact on virulence; S. aureus expressing FnBPA variants
with no or few FnBRs are significantly less virulent
compared to FnBPA with the full complement of repeats.
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were sufficient to confer the same level of binding to Fn as S. aureus
expressing the full length protein (or for consistency in nomencla-
ture here FnBPR1-11) (Fig. 3A). Despite binding Fn at a lower
level, a single high-affinity repeat (FnBPR1 or FnBPR11) was
sufficient to confer equivalent invasion of endothelial cells when
compared with the full length protein. A single low-affinity repeat
(FnBPR2 or FnBPR8) did not confer any binding to Fn above that
observed for the knockout strain, but the addition of an extra low-
affinity repeat (FnBPR7,8) did increase this, albeit at a significantly
lower level when compared with the high-affinity repeats (Fig. 3A).
Three low-affinity repeats (FnBPR6–8) were needed before
adhesion to Fn or invasion of endothelial cells was equivalent to
that conferred by the full length protein (Fig. 3A, B).
Selected constructs were also expressed in the mouse-derived S.
aureus strain LS-1. Initial experiments were performed to assess the
expression levels of each of the constructs by ELISA using anti-
FnBPA antibodies (Fig. 4A) and fibrinogen binding (Fig. 4B), as
described above for 8325.4. As for 8325.4, LS-1 WT expressed
FnBPA at lower levels than the plasmid-encoded gene. Expression
levels were equivalent between variants (Fig. 4A). LS-1 WT and
FnBPA-defective strains both bound fibrinogen (due to the
presence of fibrinogen-binding proteins ClfA and ClfB [14]) but
LS-1 strains expressing each of the FnBPA variants bound in 2-
fold greater numbers (Fig. 4B), reflecting the higher levels of
FnBPA expression that occurs when the gene is located on the
plasmid. There were no differences in binding levels between
plasmid-encoded FnBPA variants (Fig. 4B). Binding to either
human or murine Fn was dependant on the presence of at least 1
FnBR (Fig. 4C, D). Similarly, invasion of EA. hy926 cells was
dependent on the presence of at least a single high-affinity FnBR
(Fig. 4E).
A nisin-inducible system facilitates controlled surface
expression of FnBPA variants
Although FnBPA variants expressing a single or very few high-
affinity repeats were able to mediate adhesion and invasion at the
same level as full length FnBPA, we considered the possibility that
the relatively high levels of protein expression of the constructs
Figure 1. Construction of FnBPA variants containing various repeats. A. Diagrammatic representation of FnBPA, illustrating the relative
positions of the N-terminal signal sequence (SS), N-terminal sub-domains (N1, N2 and N3) forming the A domain, 11 Fn-binding repeats (numbered
1–11; those with high affinity for Fn are indicated with asterices), proline-rich region (PRR) and the sortase A recognition sequence LPXTG. The FnBPA
variants described in this report differ solely in the composition of the Fn-binding repeat region. Thus FnBPR0 refers to FnBPA without any repeats,
FnBPR1 contains only repeat 1 whilst FnBPR1-11 encodes the entire fnbA gene etc. The old organizational scheme is shown below the new one. B.
Construction strategy used to produce fnbA variants containing various combinations of repeats. PCR primers with 59 phosphate were employed to
amplify the entire pFNBA4 plasmid, minus the repeats to be excluded. The blunt ended phosphorylated DNA could then be self-ligated using T4 DNA
ligase forming a plasmid containing the modified fnbA gene. C. Diagrammatic representation of the composition of the Fn-binding domains of FnBPA
variants used in this study. Each square represents a single repeat. Filled squares and open squares represent high- and low-affinity repeats
respectively. D. Western immunoblots of surface proteins from S. aureus expressing various FnBPA constructs. FnBPA variants were detected using an
antibody that recognizes the N-terminal domain that is common to all the constructs used in this study. Blots are labelled according to the repeats
present in each of the FnBPA variants expressed.
doi:10.1371/journal.ppat.1000964.g001
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(Fig. 2A, B) might mask important differences between full length
FnBPA and variant forms. As such we chose the following
constructs for further study; FnBPR1-11 (full-length protein),
FnBPR1 (single high-affinity repeat), FnBPR2 (single low-affinity
repeat) and FnBPR1, 10, 11 (3 high-affinity repeats and binds and
invades equivalently to FnBPR1-11). FnBPR0 was included as a
control as it wouldn’t be expected to bind or invade at any
expression level. To assess how selected FnBPA variants might
affect adhesion and internalization at lower expression levels an
inducible expression system was employed [35]. This and similar
systems have been used previously to vary expression levels of
several Gram-positive proteins on the surface of L. lactis [35–37].
Surface expression of FnBPA variants was quantified by ELISA
using antibodies to the A domain of FnBPA (which is common to
all variants). Analysis of L. lactis expressing FnBPR1-11 grown in a
range of nisin concentrations (0–200 ng ml21) revealed that, in
keeping with previous reports [35,36], low-level expression
occurred in the absence of nisin (Fig. 5A). A dose-dependent
increase in FnBPR1-11 expression was seen with increasing
concentrations of nisin up to 200 ng ml21 (Fig. 5A), beyond which
bacterial growth was inhibited (data not shown). Expression levels
of each of the FnBPA variants were equivalent when identical nisin
concentrations were used (Fig. 5A). In addition to the ELISA we
employed a fibrinogen-binding assay to assess FnBPA function as
the A domain, which is constant in all our constructs, is known to
bind fibrinogen (Fig. 5B). In the absence of nisin L. lactis expressing
each FnBPA variant bound fibrinogen at very low levels, which
increased in a dose-dependent manner and were equal at nisin
concentrations .10 ng ml21 (Fig. 5B). Adhesion to fibrinogen at
lower surface expression levels (,10 ng ml21) was variable and, in
keeping with recent work [13], suggested that FnBR1 is required
for optimal binding to this ligand.
Multiple FnBRs within FnBPA support Fn adhesion and
trigger bacterial internalization at low levels of surface
expression
The abilities of five FnBPA variants to adhere to Fn and to
trigger bacterial internalization were compared over a range of
expression levels. In the absence of nisin, L. lactis expressing
FnBPR1-11 adhered strongly to Fn (Fig. 6A). Increasing FnBPR1-
11 expression (0–10 ng ml21 nisin) promoted adhesion 2.5-fold
before reaching saturation (Fig. 6A). These results mirrored those
seen for bacterial internalization, with high levels occurring at
basal (absence of nisin) FnBPA expression levels, which increased
steadily (.10-fold) before reaching a plateau, also at 10 ng ml21
nisin (Fig. 6B). By contrast, binding to Fn or invasion of
endothelial cells by L. lactis expressing FnBPR0 (no Fn-binding
repeats) was not enhanced at any level of expression (Fig. 6). At
basal expression levels L. lactis expressing FnBPR1 (containing a
single high-affinity repeat) bound to Fn at a low level and was not
internalized (relative to FnBPR0, Fig. 6). However, both adhesion
and invasion levels increased dramatically (20-fold and 63–fold
respectively) with increasing levels of expression, eventually
reaching similar levels to that of FnBPR1-11 at saturation
(Fig. 6). Adhesion of L. lactis expressing FnBPR2 (containing a
single low-affinity repeat) to Fn occurred only at levels of induction
.1 ng ml21 nisin and increased in a dose-dependent manner,
eventually reaching levels similar to that supported by FnBPR1 at
100 ng ml21 nisin (Fig. 6A). However, FnBPR2 did not trigger
bacterial internalization at any expression level (Fig. 6B).
The adhesion profile of L. lactis expressing FnBPR1,10,11
(containing 3 high-affinity repeats) was very similar to that of
FnBPR1-11 (Fig. 6A). At the basal-level of expression L. lactis
FnBR1,10,11 triggered invasion at levels 3.5-fold lower than full
length FnBPR1-11 but 3-fold higher than FnBPR1. Invasion levels
increased with increasing nisin concentration, reaching the same
level as full length FnBPR1-11 at 10 ng ml21 (Fig. 6B).
Together these findings suggest that although a single high
affinity repeat can confer wild-type levels of adhesion and invasion,
its expression needs to reach a high density before it can do so.
The expression of multiple repeats within a single molecule allows
invasion of endothelial cells at low FnBPA surface density.
The rate of invasion of endothelial cells is directly
associated with the density of binding repeats expressed
on the surface of bacteria
Fn-binding proteins of pathogenic bacteria are believed to cause
clustering of cell-surface integrins, leading to cell signalling events
that trigger uptake of the bacterium [24]. We hypothesized that
multiple FnBRs might trigger uptake in a more efficient manner
than a single repeat, leading to an increased rate of bacterial
internalization. To assess this we determined the number of
adherent and internalized bacteria at various time points from 15
to 60 minutes post-incubation with endothelial cells. Figures 7A
Table 1. PCR primer sequences, templates and primer combinations used to make fnbA variants.
Template Primer A Sequence Primer B Sequence Product
pFnBA4 C For CCAATCGTGCCACCAACGCC N Rev ATTTTTCTCATTTCCGTTCGC pFnBPR0
C For CCAATCGTGCCACCAACGCC R1 Rev TGATGAATCATATTCCTCTTCAAC pFnBPR1
R9 For AAATATGAACAAGGTGGCAATATCG N Rev ATTTTTCTCATTTCCGTTCGC pFnBPR9–11
R10 For AAGTATGAACATGGCGGTAAC N Rev ATTTTTCTCATTTCCGTTCGC pFnBPR10,11
R11 For AGTTATCAATTCGGTGGACAC N Rev ATTTTTCTCATTTCCGTTCGC pFnBPR11
R10 For AAGTATGAACATGGCGGTAAC R1 Rev TGATGAATCATATTCCTCTTCAAC pFnBPR1,10,11
C For CCAATCGTGCCACCAACGCC R2 Rev TGATGAATCCGTTTCTTCTATTGTTTC pFnE1,2
C For CCAATCGTGCCACCAACGCC R8 Rev CACGTTGATATTAAGAGTGAATTAGG pFnR1–8
pFnBPR1,2 R2 For ACTCTTGACATTGATTACCACACAG N Rev ATTTTTCTCATTTCCGTTCGC pFnBPR2
pFnBPR1–8 R6 for GAATATACAACTGAAAGTAATC N Rev ATTTTTCTCATTTCCGTTCGC pFnBPR6–8
pFnBPR6–8 R7 For AACAATCATCATATTTCTC N Rev ATTTTTCTCATTTCCGTTCGC pFnBPR7,8
pFnBPR6–8 R8 for CACGTTGATATTAAGAGTG N Rev ATTTTTCTCATTTCCGTTCGC pFnBPR8
doi:10.1371/journal.ppat.1000964.t001
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and 7B show that adhesion of FnBPA-expressing bacteria to the
endothelial cell surfaces was consistent between variants over time.
Indeed, adhesion to this cell line does not appear to depend on
fibronectin binding since S. aureus FnBPR0 binds as efficiently as
FnBPR1-11 (data not shown). S. aureus expressing full length
FnBPR1-11 showed a continual increase in the number of
internalized bacteria over this time period, reaching a plateau at
45–60 minutes (Fig. 7C). S. aureus expressing only a single repeat
(FnBPR1) had approximately 20-fold fewer internalized bacteria
after 15 minutes compared with the full length protein but this
difference became less pronounced with increasing incubation
time, and there was no significant difference in the number of
internalized bacteria after 60 minutes (Fig. 7C). S. aureus expressing
three high affinity repeats invaded more quickly than those
expressing a single repeat but less quickly that those expressing all
11 repeats, supporting the hypothesis that multiple repeats
increase the rate at which S. aureus can invade cells. These results
were verified by examining invasion mediated by full length
FnBPA on the surface of L. lactis at varying densities (Fig. 7D).
After 60 minutes’ incubation of bacteria and endothelial cells L.
lactis expressing all densities of FnBPA had invaded at similar
levels, but at 15 and 30 minutes incubation a clear association
between surface density and bacterial uptake could be seen
(Fig. 7D).
Uptake mechanisms do not differ with varying densities
of binding repeats
Although triggered by FnBPA, staphylococcal entry into
endothelial cells involves host cell processes [18,20]. There
appear to be two major mechanisms of invasion of human cells
by pathogenic bacteria, the first involving integrin-triggered
Figure 2. FnBPA variants are expressed at equivalent levels on
the surface of S. aureus 8325.4. A. Reactivity of anti-N-terminal
FnBPA antibodies with S. aureus 8325.4 WT and a Dfnb isogenic mutant
expressing plasmid-encoded FnBPA variants. An isogenic mutant
deficient in FnBPs (Dfnb) was used as a blank to control for interference
by protein A. Standard plots of ELISA values against FnBPA can be
found in Figure S1. B. Binding of S. aureus 8325.4 expressing FnBPA
variants to fibrinogen immobilized onto plastic wells. Wild-type (WT) S.
aureus 8325.4, an isogenic mutant deficient in FnBPs (Dfnb) and the
isogenic mutants expressing a range of different FnBPA variants to Fn
(1 mg per well) was assessed after incubation at 37uC for 1 h. Binding
levels that were significantly different (p =,0.05) from FnBPR0 are
indicated (*). Experiments were repeated 4 times in duplicate.
doi:10.1371/journal.ppat.1000964.g002
Figure 3. Composition of the Fn-binding repeat region
significantly affects adhesion and internalization of S. aureus
8325.4. A. Adhesion of S. aureus expressing FnBPA variants to Fn
immobilized onto plastic wells. Wild-type (WT) S. aureus 8325.4, an
isogenic mutant deficient in FnBPs (nfnb) and the isogenic mutants
expressing a range of different FnBPA variants to Fn (1 mg per well) was
assessed after incubation at 37uC for 1 h. Binding levels that were
significantly different (p =,0.05) from FnBPR1-11 are indicated (*).
Experiments were repeated 4 times in duplicate. B. Uptake of S. aureus
expressing FnBPA variants by EA. hy926 endothelial cells. The number
of intracellular bacteria, including wild-type (WT) S. aureus 8325.4, an
isogenic mutant deficient in FnBPs (Dfnb) and the isogenic mutants
expressing a range of different FnBPA variants, within EA. hy926 cells
was determined after incubation at 37uC in 5% CO2 for 1 h using the
gentamicin protection assay (see Materials and Methods section). In
each case experiments were repeated 4 times in duplicate wells.
Invasion levels that were significantly different (p =,0.05) from
FnBPR1-11 are indicated (*).
doi:10.1371/journal.ppat.1000964.g003
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remodelling of actin and the second making use of host cell
structures known as caveolae [24]. In keeping with previous
reports [24–26], the invasion of the cells used in this study by S.
aureus appears to occur via an actin remodelling mechanism (Fig.
S2). As the rate of bacterial internalization was affected by
FnBPA composition and surface density, we hypothesized that
this variation might reflect the triggering of different cellular
uptake mechanisms. To examine this we investigated the mode of
entry of S. aureus expressing FnBPR1-11 and FnBPR1, as well as
L. lactis expressing FnBPR1-11 at high or low surface densities,
using inhibitors of cellular processes. Consistent with wild-type S.
aureus 8325.4 (Fig. S2D), internalization of S. aureus expressing
either FnBPR1-11 or FnBPR1 was unaffected by genistein or
methyl-b-cyclodextrin but was inhibited by Wortmannin and
cytochalasin D (Fig. 8A). Although uptake of both S. aureus
expressing FnBPR1-11 and FnBPR1 was slightly reduced by the
Src kinase inhibitor PP2, it was only significant for FnBPR1
(p =,0.05) (Fig. 8A). L. lactis expressing FnBPR1-11 was
similarly affected, regardless of expression level (Fig. 8B).
Internalization of bacteria weakly (absence of nisin) or strongly
(200 ng ml21 nisin) expressing FnBPR1-11 was inhibited by
wortmannin and cytochalasin D but not genistein or methyl-b-
cyclodextrin (Fig. 8B). Inhibition of L. lactis uptake by PP2 was
much more pronounced than for S. aureus, particularly at low
expression levels (Fig. 8). These findings verify that the density of
Fn-binding repeats does not affect the uptake mechanism
exploited by the bacteria.
Full-length FnBPA facilitates bacterial adhesion to
immobilized Fn in the presence of soluble Fn
Blood contains high levels of soluble (plasma) Fn. Although
FnBPA has been shown to bind fluid-phase Fn [20], we
hypothesized that to bind the endothelium in vivo S. aureus must
be able to bind preferentially to immobilized (cell bound) Fn. To
test this we measured the adhesion of bacteria expressing FnBPA
variants to immobilized fibronectin in the presence of increasing
concentrations of soluble fibronectin. Adhesion of S. aureus
expressing FnBPR1-11 to immobilized Fn was unaffected by
the presence of soluble Fn except at the highest concentrations
used (Fig. 9). By contrast, Fn-binding by S. aureus expressing
FnBPA variants containing one or three repeats was significantly
inhibited at low concentrations of soluble Fn (Fig. 9). This
suggests that full-length FnBPA is likely to be significantly more
efficient at conferring adhesion to the endothelium under in vivo
conditions.
Figure 4. Expression levels and phenotype of S. aureus LS-1 expressing FnBPA variants. Reactivity of anti-N-terminal FnBPA antibodies
with S. aureus LS-1 WT and a Dfnb isogenic mutant expressing plasmid-encoded FnBPA variants. An isogenic mutant deficient in FnBPs (Dfnb) was
used as a blank to control for interference by protein A. Standard plots of ELISA values against FnBPA can be found in Figure S1. B. Binding to human
fibrinogen (1 mg per well) by S. aureus LS-1 wild-type (WT), Dfnb and Dfnb expressing FnBPA variants. Binding was assessed after incubation at 37uC
for 1 h. Binding levels that were significantly different (p =,0.05) from FnBPR0 are indicated (*). C. Attachment to murine Fn (1 mg per well) by the
same strains described above. Binding levels that were significantly different (p =,0.05) from WT are indicated (*). D. Attachment to human Fn (1 mg
per well) by the same strains. Binding levels that were significantly different (p =,0.05) from WT are indicated (*). All binding assays were repeated 4
times in duplicate wells. E. Uptake by EA. hy926 endothelial cells by the same strains. The number of intracellular bacteria was determined after
incubation at 37uC in 5% CO2 for 1 h using the gentamicin protection assay (see Experimental procedures section). In each case experiments were
repeated 4 times in duplicate wells. Invasion levels that were significantly different (p =,0.05) from WT are indicated (*).
doi:10.1371/journal.ppat.1000964.g004
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Fibronectin-binding does not affect S. aureus survival or
modulate TNFa production in whole human blood
S. aureus has a number of mechanisms that aid evasion of the
host immune system including surface adhesins such as Clf and
Spa that inhibit phagocytosis [4]. Work with Streptococcus pyogenes
suggested that the Fn-binding protein PrtF, which is structurally
similar to FnBPA, inhibits phagocytosis in a whole blood model
[38]. As such, we assessed whether the FnBR region of FnBPA
might perform a similar function. Using a similar whole blood
model (see Materials and Methods section), we determined the
survival of S. aureus strains 8325.4 and LS-1 expressing full length
FnBPA (FnBPR1-11) or the FnBR-deficient variant FnBPR0.
Over a period of up to 6 h there were no significant differences in
bacterial CFU between strains expressing FnBPR1-11 or the
FnBR-deficient FnBPR0 (Fig. 10A), indicating that fibronectin
binding does not affect S. aureus survival.
In addition, we assessed whether Fn-binding might affect the
inflammatory response of whole blood to S. aureus by determining
the production of TNFa triggered by each strain. All bacteria
examined elicited TNFa expression that was significantly greater
than that of whole blood incubated without bacteria (Fig. 10B).
Although there was a significant difference between strains, the
FnBR-region of FnBPA had no effect on TNFa production by
whole blood (Fig. 10B).
Figure 6. Full-length FnBPA supports adhesion and invasion even at low surface density. A. L. lactis FnBPR1-11 (open circles), FnBPR0 (squares),
FnBPR1 (triangles), FnBPR2 (closed circles) and FnBPR1,10,11 (diamonds) were grown to stationary phase in the presence of various concentrations of nisin
and assessed for their ability to bind Fn. Experiments were repeated 4 times in duplicate. B. L. lactis strains were cultured as described in (A) and their abilities
to trigger uptake by EA. hy926 cells measured by the gentamicin protection assay. Experiments were repeated 4 times in duplicate.
doi:10.1371/journal.ppat.1000964.g006
Figure 5. Nisin controlled expression of FnBPA in L. lactis is consistent between variants. A. Expression of FnBPA variants (as assessed by
A450 readings) by L. lactis FnBPR1-11 (open circles), FnBPR0 (closed squares), FnBPR1 (triangle), FnBPR2 (open squares) and FnBPR1,10,11 (diamonds)
grown to stationary phase (16 h) in the presence of increasing concentrations of nisin (0–200 ng ml21). B. Adhesion of L. lactis FnBPR1-11 (open
circles), FnBPR0 (closed squares), FnBPR1 (triangle), FnBPR2 (open squares) and FnBPR1,10,11 (diamonds) to immobilized fibrinogen after growth to
stationary phase in the presence of increasing concentrations of nisin (0–200 ng ml21). Values that were significantly different (p =,0.05) from
FnBPR1-11 are indicated (*). Experiments were repeated 3 times in duplicate.
doi:10.1371/journal.ppat.1000964.g005
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Multiple FnBRs are essential for full virulence in a murine
sepsis model
We hypothesized from our in vitro data that bacteria expressing
FnBPA variants with multiple repeats would be able to bind to and
invade endothelium more efficiently in vivo than bacteria
expressing FnBPA variants with few or no repeats, causing greater
levels of mortality. To test this we employed a murine sepsis model
to assess the virulence of S. aureus LS-1 (a mouse infective strain)
expressing FnBPA variants. S. aureus LS-1 Dfnb expressing
FnBPR0, FnBPR1, FnBPR1,10,11 or FnBPR1-11 were pheno-
Figure 7. FnBPA composition and expression level modulate the rate of bacterial internalization. A. Total number of S. aureus 8325.4
expressing FnBPR1-11 (circles), FnBPR1 (squares) and FnBPR1,10,11 (triangles) associated (adherent and internalized) with endothelial cells at various time
points. Values that were significantly different (p=,0.05) from FnBPR1-11 are indicated (*). Experiments were repeated 3 times in duplicate. B. Total
number of L. lactis expressing FnBPA associated with endothelial cells at various time points after growth in the presence of nisin at 0.1 ng ml21 (closed
circles), 1.0 ngml21 (triangles) or 200 ngml21 (diamonds). Values that were significantly different (p=,0.05) from L. lactis FnBPR1-11 grown in 0.1 ngml21
nisin are indicated (*). Experiments were repeated 3 times in duplicate. C. Internalization of S. aureus FnBPR1-11 (circles), FnBPR1 (squares) and FnBPR1,10,11
(triangles) by EA. hy926 cells over time. Values that were significantly different (p=,0.05) from FnBPR1-11 are indicated (*). Experiments were repeated 3
times in duplicate. D. Internalization of L. lactis FnBPR1-11 grown in the presence of nisin at 0.1 ng ml21 (closed circles), 0.5 ng ml21 (squares), 1.0 ng ml21
(triangles), 10 ng ml21 (open circles) and 200 ng ml21 (diamonds) by EA. hy926 cells over time. Values that were significantly different (p=,0.05) from L.
lactis FnBPR1-11 grown in 200 ng ml21 nisin are indicated (*). Experiments were repeated 3 times in duplicate.
doi:10.1371/journal.ppat.1000964.g007
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typically similar to 8325.4 Dfnb expressing the same constructs
with respect to Fn-binding and invasion of endothelial cells (Fig. 3).
Mice were injected intravenously with one of these four S. aureus
LS-1 strains and survival and weight loss monitored over 14 days.
By day 9, S. aureus expressing full length FnBPR1-11 had killed
.60% of mice, which was significantly greater than any of the
three other strains (p =,0.007, Fig. 11A). Those that survived
continued to suffer significant weight loss of approximately 30%,
suggesting severe infection (Fig. 11B). By contrast, no significant
difference in mortality was observed between S. aureus expressing
FnBPR0, FnBPR1 or FnBPR1,10,11, which killed up to 20% of
the mice (Fig. 11A). The pattern of weight loss was also similar
between these three strains, although mice infected with S. aureus
expressing FnBPR1 and FnBPR1,10,11 showed significantly
different weight changes between days 4 and 13 after inoculation
(p = 0.02, Fig. 11B).
In addition to measurements of mortality and weight loss we
also assessed bacterial numbers (CFU) in the kidneys 3 days after
inoculation (Fig. 11C). This time point was chosen because
previous experiments (Fig. 11A, B) indicated that it was close to the
initiation of mortality (indeed, one mouse in the FnBPR1-11 group
died before sacrifice). As expected from the data in Figures 11A
and 11B, the kidneys of mice inoculated with S. aureus FnBPR1-11
contained significantly more CFU than the kidneys of mice
infected with S. aureus FnBPR0 (23-fold greater, p = 0.0022). S.
aureus FnBPR1-11 was also approximately 6-fold more abundant
than S. aureus expressing either FnBPR1 or FnBPR1,10,11
(p = 0.024). There was no significant difference in the bacterial
load between S. aureus FnBPR0, FnBPR1 or FnBPR1,10,11. We
also used the bacterial colonies from the kidneys to determine loss
of the FnBPA-encoding plasmids (Fig. 11D). Plasmid loss was
highly variable between animals but was not significantly different
between FnBPA variants and did not correlate with bacterial load
(data not shown). The difference between S. aureus expressing
FnBPR0, FnBPR1 or FnBPR1,10,11 when compared with those
Figure 8. The mechanism of bacterial uptake is unaffected by FnBPA composition or expression level. The number of bacteria taken up
by untreated cells (CTL) or those pre-treated with genistein (GEN), methyl-b-cyclodextrin (MCD), wortmannin (WRT), cytochalasin D (CD) or PP2 were
measured using the gentamicin protection assay. A. EA. hy926 uptake of S. aureus expressing either full length FnBPA (FnBPR1-11, open bars) or
FnBPA containing just repeat 1 (FnBPR1, closed bars) after treatment with inhibitors. B. Internalization of L. lactis FnBPR1-11 expressing either low
levels of FnBPR1-11 (absence of nisin, open bars) or high levels (200 ng ml21 nisin, closed bars) into cells treated with the same inhibitors used in
panel A. Graphs represent the mean of 3 independent experiments performed in duplicate with error bars indicating the standard deviation of the
mean. Conditions that significantly (p =,0.05) inhibited internalization are indicated (*).
doi:10.1371/journal.ppat.1000964.g008
Figure 9. Full length FnBPA facilitates adhesion to immobilized
Fn in the presence of soluble Fn. Binding of S. aureus expressing
various FnBPA variants to Fn immobilized in plastic wells, in the
presence of increasing concentrations of fluid-phase Fn. Values that
were significantly different (p =,0.05) from binding in the absence of
soluble protein (PBS only) are indicated (*). Experiments were repeated
3 times in duplicate.
doi:10.1371/journal.ppat.1000964.g009
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expressing full length FnBPR1-11 demonstrates that full length
FnBPA is required for full pathogenicity in this model, most likely
during the early stages of infection.
Discussion
Bacterial invasion of host cells is a process common to many
pathogens. It likely aids evasion of extracellular immune factors
and provides a protected niche from antibiotics, and can therefore
allow bacteria to cause persistent and recurrent infections [39,40].
Additionally, bacterial invasion of the endothelium can lead to
inflammation, endocarditis and may lead to traversal of blood
vessels and subsequent formation of metastatic infections [22]. As
such it is crucial that we gain a greater understanding of how this
pathogen interacts with the host to identify means of blocking
these infections [1].
There is clear and compelling evidence that FnBPA alone is
sufficient to trigger S. aureus invasion of cells via Fn bridging to
a5b1 integrins [18,20]. Previous work revealed that staphylococcal
attachment to Fn and invasion of host cells is maintained even
when substantial portions of the Fn-binding region have been
deleted [13,19]. As such, it was unclear what benefits are conferred
by multiple FnBRs. As there is evidence that a single FnBPA
molecule is able to bind up to nine Fn molecules [33], we
hypothesized that a minimum number of repeats in close
proximity would be required to trigger Fn clustering and
subsequent integrin clustering, which leads to cell invasion
[32,33]. Furthermore, we hypothesized that the composition of
FnBPA variants with respect to high- and low-affinity repeats
would affect adhesion and internalization. Here we show that high
surface densities of repeats are required for adhesion and
internalization in vitro. However, it is not important to have
multiple repeats within a single FnBPA molecule because high
level expression of individual FnBPA variants containing a single
high-affinity binding repeat results in invasion at WT levels (Fig. 6).
In addition to demonstrating that high surface density of FnBRs
promotes cell invasion, we show that speed of uptake is modulated
by composition and expression level of FnBPA (Fig. 7).
Although the data presented here suggest that Fn binding is
indicative of the potential to trigger invasion, our studies using
low-affinity repeats suggest a more complicated situation. The
inability of the FnBPA variant containing a single low-affinity
repeat (FnBPR2) to trigger internalization at high surface
expression levels, despite supporting adhesion to Fn, suggests that
invasin-receptor affinity is crucial (Fig. 6). Three tandem low-
affinity repeats however support invasion (Fig. 3). It is therefore
possible that certain FnBPA-Fn interactions induce a conforma-
tional change in the glycoprotein, which triggers integrin signalling
and bacterial uptake. In vivo, S. aureus will not only encounter cell-
bound Fn but also the soluble form. Although adhesion of S. aureus
expressing FnBPR1 and FnBPR1,10,11 to immobilized Fn was
significantly inhibited at even low concentrations of soluble Fn, S.
aureus FnBPR1-11 was only affected at the highest concentration
used (Fig. 9). This suggests that the three other high-affinity repeats
(4, 5 and 9) and perhaps also the five low-affinity repeats (2, 3, 6, 7
and 8) are important in overcoming the presence of soluble ligand.
Although our data suggest that, in tandem, multiple low-affinity
repeats can perform almost as well as single high-affinity repeats, it is
not clear what advantage the bacteria gain from maintaining these
repeats. The answer may lie in studies of the immune response to
FnBPA during staphylococcal infection. Analysis of a panel of
antisera from different patients demonstrated that antibodies
recognizing the Fn-binding region do not inhibit bacterial binding
of Fn [41]. Furthermore, the binding of these antibodies to FnBPA
was enhanced in the presence of Fn, presumably due to the creation
of ligand-induced binding sites [41]. A more recent study revealed
that despite strong antibody recognition of high-affinity repeats when
complexed with Fn, there was significantly lower recognition of low-
affinity repeats either in the presence or absence of the glycoprotein
[31]. As such, the lack of antibody recognition of low-affinity repeats
may allow the bacteria to adhere to host tissues even in the presence
of anti-FnBPA antibodies.
Figure 10. The Fn-binding region of FnBPA does not affect bacterial survival or TNFa production in whole human blood. A. Survival
of S. aureus 8325.4 expressing FnBPR1-11 (open circles) or FnBPR0 (closed circles) and LS-1 expressing FnBPR1-11 (closed squares) or FnBPR0 (open
squares) in whole human blood over time. Aliquots of blood were assayed for CFU at the indicated time points. Experiments were repeated 3 times.
B. Production of TNFa by whole human blood in response to S. aureus strains 8325.4 and LS-1 expressing either FnBPR1-11 or FnBPR0. Samples were
taken after 6 hours and TNFa concentration measured by ELISA. Blood incubated in the absence of bacteria served as a negative control (CTL).
Experiments were repeated 3 times.
doi:10.1371/journal.ppat.1000964.g010
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A role for FnBPA in sepsis has been previously established [14],
although it was not clear whether the fibrinogen- and elastin-binding
region or the Fn-binding region was important. Using the same
model of sepsis we show that the FnBRs are required for virulence
(Fig. 11). We also show that increased efficiency of the full length
protein (FnBPR1-11) at mediating binding to Fn and cell invasion
translates into a difference in virulence. Despite the ability to bind Fn
and invade cells in vitro, neither S. aureus expressing FnBPR1 nor
FnBPR1,10,11 were any more virulent than that expressing FnBPR0.
The enhanced pathogenesis conferred by multiple FnBRs does not
appear to be due to elevated survival in blood or the stimulation of
pro-inflammatory TNFa. However, the greater bacterial load in the
kidneys of mice infected with S. aureus FnBPR1-11, compared with
FnBPR0 or FnBPR1, suggests that multiple repeats significantly
enhance systemic invasion.
The demonstration of the role of FnBPA in septic death does
not rule out the involvement of other staphylococcal factors in the
progression of infection. Indeed, a role for clumping factor in
sepsis using this model and strain has been shown previously [41]
and it is likely that different factors will be required at different
stages of the infective process [1]. Experiments examining the loss
of FnBPA-encoding plasmids from infecting bacteria suggest that
this protein acts early in the infectious process and its retention is
not required for the latter stages of infection. Significant plasmid
loss at day 3 is unsurprising since the bacterial load for S. aureus
FnBPR1-11 is 10 times greater than the inoculum, indicating
significant replication within this organ. These data indicate that
the FnBRs within FnBPA significantly enhance bacterial exit from
the blood and colonization of the kidneys soon after entry into the
vascular system. This is supported by previous in vivo experiments
that showed S. aureus attachment to the endothelium is dependent
on FnBPA and occurs within 5 minutes of inoculation [21]. Once
colonization is established, S. aureus is likely to employ other
virulence factors (e.g. other surface proteins, toxins and proteases),
Figure 11. Multiple FnBRs are necessary for full virulence in a murine sepsis model. A. Mice (groups of 15) were inoculated intravenously
with approximately 1.16107 S. aureus LS-1 Dfnb expressing FnBPR1-11 (inverted triangles), FnBPR0 (circles), FnBPR1 (squares) or FnBPR1,10,11
(triangles) and survival followed until day 15. B. Weight change in mice infected with strains as described in (A). C. Bacterial load in the kidneys of
mice inoculated with bacteria described above. Two independent groups of mice (4 per group) were sacrificed on day 3, their kidneys removed and
the number of CFU determined. One mouse in the FnBPR1-11 group died before day three. Two mice each in the FnBPR0 and FnBPR1,10,11 groups
did not have detectable numbers of bacteria (,99 CFU). Values that are significantly different (p =,0.05) from S. aureus FnBPR1-11 are indicated (*).
D. Plasmid loss by S. aureus isolated from kidneys 3 days after inoculation. Bacterial colonies used to enumerate bacterial loads in the kidneys were
assessed for resistance to chloramphenicol and thus presence or absence of the FnBPA-encoding plasmid.
doi:10.1371/journal.ppat.1000964.g011
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which together with host factors, promote progression to abscess
formation [1], leading to weight loss and mortality. However, early
extravasation, mediated by FnBPA containing multiple FnBRs,
appears to be essential for full virulence.
In summary, the presence of multiple FnBRs within FnBPA
results in a high surface density of Fn-binding sites. This triggers a
rapid invasion of endothelial cells even at low surface expression
levels and enables binding in the presence of soluble ligand. This
appears to be particularly relevant to pathogenesis and the
development of systemic infection.
Materials and Methods
Ethics statement
Approval for experiments using human blood was granted by
the Bath Research Ethics Committee (NHS National Research
Ethics Services, reference 08/H0101/18). Donors gave informed
consent in writing prior to the commencement of any procedures.
Approval for animal experiments was granted by the Go¨teborg
Animal Experimentation Ethics board and their ethical and
husbandry guidelines followed for all experiments. NMRI mice
were obtained from Charles River (Sulzfeld, Germany) and were
maintained in the animal facility of the Department of
Rheumatology, University of Go¨teborg, Sweden. Mice were
housed up to 10 animals per cage with a 12 h light-dark cycle,
and were fed standard laboratory chow and water ad libitum. The
animals were 8 weeks old at the start of the experiments.
The overall condition of each mouse was examined by assessing
signs of systemic inflammation, i.e. weight decrease, reduced
alertness, and ruffled coat. In keeping with approved husbandry
standards, in cases of severe systemic infection, when a mouse was
judged too ill to survive another 24 h, it was killed by cervical
dislocation and considered dead due to sepsis.
Bacterial strains and growth conditions
A detailed list of the strains used in this study is presented in
Table 2. S. aureus strains were cultured for 16 h in Brain-Heart
Infusion (BHI) broth at 37uC in air with shaking. S. aureus CFU
were quantified on Tryptic Soy Agar (TSA) plates incubated
overnight at 37uC in air. L. lactis strains were cultured in M17
broth (supplemented with 0.5% w/v glucose) for 16 h at 30uC in
air (with the appropriate concentration of nisin where necessary).
Escherichia coli was grown in Luria broth at 37uC with shaking.
Where appropriate, bacteria were incubated in the presence of the
following antibiotics: ampicillin 100 mg ml21, chloramphenicol
10 mg ml21 and erythromycin 5 mg ml21 (L. lactis) or 250 mg ml21
(E. coli).
Endothelial cell culture
The cell line EA. hy926, established by the fusion of human
umbilical endothelial cells (HUVEC) and the permanent lung
epithelial carcinoma cell line A549 [42], was cultured in
Dulbecco’s Modified Eagle’s medium (DMEM; Invitrogen)
supplemented with foetal bovine serum (FBS; 10%) and L-
glutamine (2 mM) at 37uC and 5% CO2. Pooled primary
HUVECs were purchased from Lonza (Basel, Switzerland) and
cultured in endothelial basal medium supplemented with 2% fetal
bovine serum, bovine brain extract (including heparin), human
endothelial growth factor, hydrocortisone and GA-1000 (Genta-
micin & Amphotericin B) at 37uC and 5% CO2 according to
manufacturer’s instructions (Lonza).
Endothelial cells were cultured in T75 flasks to approximately
95% confluency, liberated with trypsin-EDTA, resuspended in the
relevant culture medium and added to 24-well plates containing
thermanox glass coverslips [19]. Plates were incubated for 48 h as
described above before the coverslips were removed, dip washed
in PBS and added to new 24-well plates containing fresh medium
and bacteria [19]. In experiments using metabolic inhibitors, these
were incubated with the cells 1 h prior to the addition of bacteria
and concentrations maintained during the assay; genistein
(200 mM), wortmannin (20 nM), cytochalasin D (50 mM), PP2
(10 mM) and methyl-b-cyclodextrin (2 mM).
Construction of FnBPA variants
FnBPA constructs containing various combinations of Fn-
binding repeats were produced using a circular PCR system based
on that described by Massey et al. [19]. Primers were designed to
various repeats or DNA just outside of the fnbA repeat region and
were synthesized with 59 phosphorylation in order to allow self-
ligation of the PCR product. Primer sequences and the
combinations used to produce the various products can be found
in Table 1. Plasmid pFnBA4 [34] was used as a template for the
amplification of DNA lacking in various repeats. PCR was
performed using Phusion high-fidelity DNA polymerase (New
England Biolabs (NEB) Ipswich, MA). Template DNA was
digested with DpnI and products cleaned using a PCR purification
kit or gel extracted (Qiagen, Hilden, Germany). Linear DNA was
self-ligated using T4 DNA ligase (NEB) to produce plasmids
containing DNA encoding the fnbA gene lacking various
combinations of FnBRs (Table 2). Ligated PCR products were
transformed into CaCl2 competent E. coli [43] and plated onto LB
agar containing 100 mg ml21 ampicillin. Selected colonies were
grown overnight in LB broth (5 ml, 100 mg ml21 Ampicillin),
bacteria pelleted by centrifugation and plasmids recovered using a
miniprep kit (Qiagen). Constructs were checked by sequencing
(Geneservice, London, UK) and transformed into S. aureus
RN4220 by electroporation. Plasmids were recovered using a
combination of lysostaphin and the Qiagen miniprep kit [19] and
re-transformed into S. aureus 8325.4 Dfnb.
Construction and controlled expression of FnBPA
variants in L. lactis
Controlled expression of FnBPA variants was achieved using a
nisin-inducible system previously used to control the expression of
the enterococcal surface protein PrgB [35]. The prgB gene was
excised from plasmid pMSP7517 using NcoI and XhoI and the
remaining plasmid recovered by gel excision. pFnBA4 and
associated constructs were used as templates for PCR reactions
using primers designed to amplify the entire fnbA gene (and repeat-
region variants) and contained NcoI (AAACCATGGAGGAGG-
TATTATAGTGAAAAACAATCTTAGG) and XhoI (AAACTC-
GAGCTAACTTTATCTCTCAGTTCGTTATC) sites respec-
tively (underlined). Digested PCR products were ligated into
digested pMSP7517 and transformed into CaCl2-treated E. coli
K12 ER2925, which was more suitable for antibiotic selection
using erythomycin than E. coli DH5a (data not shown). Plasmids
were recovered, checked by sequencing and electro-transformed
into L. lactis NZ9800 [36]. Expression was induced by culture
(16 h, 30uC) of L. lactis containing FnBPA variant constructs
(Table 2) in the presence of various concentrations of nisin (range
0–200 ng ml21). Expression levels were determined by ELISA and
binding to immobilized fibrinogen (see below).
Determination of surface protein expression by Western
immunoblot
S. aureus was cultured as described and the bacteria pelleted by
centrifugation (5,000 x g, 8 min). Bacteria were washed 3 times in
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PBS, resuspended in spheroplasting buffer (30% raffinose, Tris-
HCl pH 7.5) [27] containing 100 mg ml21 lysostaphin and
incubated for 1 h at 37uC. Spheroplasts were pelleted by
centrifugation and the supernatant containing surface proteins
recovered. Aliquots (40 ml) were mixed with 5X concentrated
sample buffer (10 ml; 50% glycerol containing 50 mM Tris-HCl
pH 6.8, 10% SDS and 10 mM 2-mercaptoethanol) and heated at
100uC for 5 min before being subjected to SDS-PAGE (7.5%
acrylamide). Separated proteins were electroblotted onto nitrocel-
lulose membrane using a BioRad (Hercules, Ca) semi-dry blotter
(25V, 1 h).
Membranes were blocked by incubation in 3% BSA (1 h) and
probed with antibodies to the N-terminal domain of FnBPA [19]
for 1 h with agitation. Membranes were washed 4 times with PBS
and incubated with HRP-conjugated goat anti-rabbit antibodies
(1 h with agitation). Membranes were subsequently washed 4
times with PBS, rinsed with ddH2O and reactive bands detected
using the Opti-4CN detection kit (BioRad).
Determination of surface protein expression by ELISA
S. aureus strains were cultured as described above, washed with
PBS, adjusted to OD600 = 0.1 and aliquots (50 ml) immobilized
onto triplicate plastic wells (Nunc Maxisorp) by incubation at 4uC
for 16 h. Wells were blocked with BSA (1 h, 4uC), washed once
with PBS and then incubated with antibodies (50 ml, 1:500 in PBS
for S. aureus 8325.4 or 1:2000 for S. aureus LS-1) raised to the A
region of FnBPA [19] for 1 h at 37uC. Wells were washed 4 times
with PBS and incubated with HRP-conjugated protein A (50 ml,
1:5000, Sigma) for 30 min at 37uC. Wells were washed a further 4
times with PBS and bound antibody detected and quantified with
100 ml TMB (3,39,5,59-tetramethylbenzidine) ELISA detection
substrate (Sigma) for 10 min at room temperature. The reaction
Table 2. Bacterial strains and plasmids used in this study.
Species/strain/plasmid Relevant characteristics Source/Reference
E.coli
E. coli DH5a Cloning host This laboratory
(pFnBA4) Shuttle vector containing the complete fnbA gene [34]
(pMSP7517) Nisin-inducible vector containing the prgB gene of Enterococcus faecalis [35]
E. coli K12 ER2925 Cloning host New England Biolabs
Staphylococcus aureus
S. aureus RN4220 Cloning host capable of sustaining shuttle plasmids [45]
S. aureus 8325.4 Wild-type, fnbA+ fnbB+ NCTC 8325 cured of prophages [46]
DU5883 fnbA- fnbB- isogenic mutant of 8325.4 [34]
DU5875 Protein A-deficient isogenic mutant of 8325.4 [47]
DU5883 (pFnBA4) (referred to here as
FnBPR1-11)
fnb - strain complemented with the plasmid pFnBA4 expressing full-length FnBPA: FnBPR1-11 [34]
pFnBPR0 Expresses FnBPA variant containing no Fn-binding repeats: FnBPR0 This study
pFnBPR1 Expresses FnBPA variant containing Fn-binding repeat 1 only: FnBPR1 This study
pFnBPR11 Expresses FnBPA variant containing Fn-binding repeat 11 only: FnBPR11 This study
pFnBPR10,11 Expresses FnBPA variant containing Fn-binding repeats 10 & 11: FnBPR10& 11 This study
pFnBPR1,10,11 Expresses FnBPA variant containing Fn-binding repeats 1, 10 & 11: FnBPR1, 10, 11 This study
pFnBPR9-11 Expresses FnBPA variant containing Fn-binding repeats 9-11: FnBPR9-11 This study
pFnBPR2 Expresses FnBPA variant containing Fn-binding repeat 2 only: FnBPR2 This study
pFnBPR8 Expresses FnBPA variant containing Fn-binding repeat 8 only: FnBPR8 This study
pFnBPR7,8 Expresses FnBPA variant containing Fn-binding repeats 7 & 8: FnBPR7,8 This study
pFnBPR6-8 Expresses FnBPA variant containing Fn-binding repeats 6-8: FnBPR6-8 This study
S. aureus LS-1 Wild-type, fnbA+ fnbB+ pathogenic in mouse model of infection [48]
S. aureus LS-1 Dfnb fnbA- fnbB- isogenic mutant of LS-1 [14]
Lactococcus lactis
L. lactis MG1363 Wild-type heterologous expression host (FnBPA/B-) [19]
pKS80 Empty expression vector [49]
pRM9 Expresses full length FnBPA of 8325-4 [19]
L. lactis NZ9800 nisA defective isogenic mutant of NZ9700 [50]
pMFnBPR1-11 Nisin controlled expression of FnBPA containing repeats 1-11: FnBPR1-11 This study
pMFnBPR0 Nisin controlled expression of FnBPA containing no repeats: FnBPR0 This study
pMFnBPR1 Nisin controlled expression of FnBPA containing repeat 1: FnBPR1 This study
pMFnBPR2 Nisin controlled expression of FnBPA containing repeat 2: FnBPR2 This study
pMFnBPR1,10,11 Nisin controlled expression of FnBPA containing repeats 1,10,11: FnBPR1,10,11 This study
doi:10.1371/journal.ppat.1000964.t002
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was stopped with 100 ml 2M HCl and product measured at
450 nm using a microplate reader.
L. lactis expressing FnBPA variants were washed in PBS as
described above, diluted 1:16 in PBS and 50 ml aliquots added to
duplicate wells of a microtitre plate as described for S. aureus. Wells
were blocked as described above and immobilized bacteria were
incubated with anti-FnBPA antibodies (50 ml, 1:1000, 1 h, 37uC)
before washing three times with PBS. Bacteria were then
incubated with HRP-conjugated anti-rabbit antibodies (50 ml,
1:5000, 1 h, 37uC) and quantified using TMB as described above.
Solid-phase Fn and fibrinogen binding assay
The adhesion of bacteria to human Fn (Sigma), murine Fn
(Biopur, Bubendorf, Switzerland) or fibrinogen (Fn-depleted,
Enzyme Research Labs, Swansea, UK) was assessed using a
protocol based on those of Jakubovics et al. and Peacock et al.
[27,44]. Fn or fibrinogen (1 mg protein in 100 ml PBS [pH 7.4] per
well) was immobilized onto plastic Nunc Maxisorp Immuno
modules by incubation at 4uC for 16 h and remaining binding sites
were blocked with 300 ml 3% BSA (in PBS) at 25uC for 1 h.
Blocked wells were washed with PBS and incubated with 100 ml
bacteria (approx. 16108 S. aureus or 56108 L. lactis in PBS) at 37uC
for 1 h. Non-adherent bacteria were removed by 3 rounds of
washing with PBS and adherent bacteria fixed with 0.25%
paraformaldehyde (5 min, 25uC). Wells were washed with PBS a
further 2 times. Fixed bacteria were stained with crystal violet
(0.5%, 2 min) before a further three rounds of washing, as
described above. Adherent, fixed bacteria were enumerated by
solubilization of crystal violet with 100 ml 7% acetic acid. The
contents of each well was quantified by measurement at A595 using
a microplate reader. For both Fn and fibrinogen binding, readings
were blanked against bacteria binding to wells coated only with
BSA. Absorbance measurements were converted to bacterial
numbers by the use of standard plots of known bacterial numbers
against A595 readings (Figure S3). These showed that the
relationship of A595 to bacterial numbers is linear (Figure S3).
Each experiment was performed at least three times. Since S. aureus
was stained more strongly with crystal violet than L. lactis (Figure
S3), different amounts of bacteria were used in assays in order to
allow bacterial quantification over as wide a range of adhesion
levels as possible.
Endothelial adhesion and invasion assays
Cultured cells were dissociated from plastic flasks using trypsin-
EDTA solution (Invitrogen) and approximately 56105 (in 0.5 ml
medium) were seeded into each well of 24-well plates (Nunc)
containing 13 mm plastic Thermanox cover slips (Fisher) and
allowed to attach for 48 h (37uC, 5% CO2). Coverslips were dip-
washed once in PBS and placed in the well of a new 24-well plate
containing 450 ml of DMEM containing 10% FBS.
To each well, 50 ml of washed bacteria were added (approx-
imately 16107 CFU S. aureus or 56107 L. lactis) and incubated for
5–90 minutes at 37uC in 5% CO2.
To measure the total number of bacteria associated with the
cells (adherent and internalized), coverslips were dip-washed 3
times in PBS and added to wells containing 500 ml 0.5% Triton X-
100. Wells containing coverslips were agitated by pipetting to fully
lyse the cells and CFU were enumerated by serial dilution and
plating onto TSA agar plates and incubated overnight at 37uC in
5% CO2.
For invasion assays, the bacterial suspension was removed and
replaced with 500 ml DMEM/10% FBS supplemented with
200 mg ml21 gentamicin and incubated at 37uC in 5% CO2 for
60 min. Coverslips were washed 3 times in PBS, lysed and plated
for CFU as described for the adhesion assay above. In assays
where metabolic inhibitors were used, these were added to cell
monolayers for 60 min prior to the experiment and concentrations
maintained during incubation with bacteria.
Statistics
For adhesion and invasion assays, statistical analyses were
performed with Student’s t test by using the Bonferroni correction
for multiple comparisons. Values that were statistically significant-
ly different from control values are indicated by asterices in the
figures. Error bars indicate the mean average 6 standard
deviation of multiple independent experiments (indicated in the
figure legend).
Whole human blood model of infection
The ability of S. aureus to survive in human blood and
generate pro-inflammatory cytokine release was assessed using a
whole human blood model. Blood from a healthy male was
drawn into heparinised tubes and used immediately. Bacteria
were washed and diluted in PBS and 10 ml (containing
approximately 20,000 CFU) was added to 800 ml blood and
incubated at 37uC for 1, 2 or 6 h with mixing. Aliquots of the
blood/bacteria mixture (5 ml) were mixed with PBS (95 ml) and
plated onto tryptic soy agar to enumerate CFU. In addition to
plating for CFU, blood at the final time point (6 h) was
centrifuged (5,000 x g, 5 min) and 100 ml serum recovered for
analysis of TNFa production using a BD OptEIA ELISA kit
(BD Biosciences, San Diego, USA).
Murine sepsis model
Groups of 15 mice were infected by intravenous injection with
S. aureus strain LS-1 Dfnb [14] expressing FnBPR1-11
(1.16107 CFU), FnBPR0 (1.16107 CFU), FnBPR1
(1.06107 CFU) or FnBPR1,10,11 (1.26107 CFU) and mortality
and weight change were followed until day 14. The clinical
evaluation was performed in a blinded manner. The overall
condition of each mouse was examined by assessing signs of
systemic inflammation, i.e. weight decrease, reduced alertness, and
ruffled coat. In keeping with approved husbandry standards, in
cases of severe systemic infection, when a mouse was judged too ill
to survive another 24 h, it was killed by cervical dislocation and
considered dead due to sepsis. The bacterial load in kidneys was
assessed as described previously [14]. Two independent groups of
4 mice were inoculated with S. aureus (as described above) and
sacrificed 3 days later. Kidney pairs were recovered and CFU
enumerated on TSA plates. Retention of the FnBPA-encoding
plasmid was determined by plating onto TSA with and without
chloramphenicol. Statistical evaluation was done by using the
Kruskal-Wallis test with a following post-hoc analysis, or the
Logrank (Mantel-Cox) test at survival analysis. P =,0.05 was
considered to be significant. No correction for multiple compar-
isons was employed. Data are reported as medians, interquartile
ranges, and 80% central ranges, unless otherwise mentioned.
Gene accession information
FnBPA variants were derived from the fnbA gene of S. aureus
8325.4, Swissprot accession SAOUHSC_02803.
Supporting Information
Figure S1 FnBPA expression ELISA standards. The reactivity of
anti-N-terminal FnBPA antibodies with S. aureus or L. lactis was
measured by ELISA over a range of two-fold dilutions from a
starting point of OD600 = 1.0. A, B. Reactivity of anti-N-terminal
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FnBPA antibodies with S. aureus 8325.4 (A) or LS-1 (B). Open
circles represent values obtained with S. aureus pFnBPR0. Open
squares represent values obtained with S. aureus Dfnb. These were
used to produce blanked values (filled triangles) that took into
account disruption caused by protein A. C. Reactivity of anti-N-
terminal FnBPA antibodies with L. lactis expressing FnBPR1-11
(induced with 10 ng ml21 nisin).
Found at: doi:10.1371/journal.ppat.1000964.s001 (0.12 MB TIF)
Figure S2 The interaction of S. aureus with EA. hy926 cells is
similar to HUVECs. A. Adhesion to and entry into EA. hy926
cells and HUVECs by S. aureus 8325.4 over time. B. Bacterial
uptake by EA. hy926 cells and HUVECs of S. aureus 8325-4 (WT),
isogenic mutants deficient in Spa (Dspa) or both fnbA and fnbB
(Dfnb) and the fnb-defective strain complemented with a plasmid
expressing full-length fnbA (Comp). C. Bacterial uptake by EA.
hy926 cells and HUVECs of L. lactis expressing fnbA (FnBPA+) or
containing an empty control plasmid (CTL). D. The uptake of S.
aureus 8325.4 by EA. hy926 cells and HUVECs treated with the
metabolic inhibitors genistein (GEN), methyl-b-cyclodextrin
(MCD), cycloheximide (CHX), wortmannin (WRT), cytochalasin
D (CD), filipin (FIL) or PP2. Untreated cells are labelled CTL.
Values that differed significantly (ttest) from untreated cells are
marked (*). Experiments were performed 3 times in duplicate
wells.
Found at: doi:10.1371/journal.ppat.1000964.s002 (1.91 MB
TIF)
Figure S3 Standard plots showing the linear relationship
between bacterial numbers and A595 when using crystal violet to
quantify bacterial adhesion.
Found at: doi:10.1371/journal.ppat.1000964.s003 (0.10 MB
TIF)
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